Volume 92, Issue 5 p. 479-490
REVIEW

Potential interventions for novel coronavirus in China: A systematic review

Lei Zhang

Lei Zhang

Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Search for more papers by this author
Yunhui Liu

Corresponding Author

Yunhui Liu

Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Correspondence Yunhui Liu, Department of Neurosurgery, Shengjing Hospital, China Medical University, No. 36 Sanhao Street, Heping, Shenyang, 110004 Liaoning, China.

Email: [email protected]

Search for more papers by this author
First published: 13 February 2020
Citations: 767

Abstract

An outbreak of a novel coronavirus (COVID-19 or 2019-CoV) infection has posed significant threats to international health and the economy. In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease. Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA-virus infection and we have found that general treatments, coronavirus-specific treatments, and antiviral treatments should be useful in fighting COVID-19. We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA-virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers. In addition, convalescent plasma should be given to COVID-19 patients if it is available. In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.